DOCSLIB.ORG

Biosynthesis of Furocoumarins: Further Studies on Ruta Graveolens

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Biosynthesis of Furocoumarins: Further Studies on Ruta Graveolens BIOSYNTHESIS OF FUROCOUMARINS 813 Biosynthesis of Furocoumarins: Further Studies on Ruta graveolens F. DALL'ACQUA, A. CAPOZZI, S. MARCIANI, and G. CAPORALE Institute of Pharmaceutical Chemistry of the University, Centro di Studio per la Chimica del Farmaco e dei Prodotti biologicamente attivi del Consiglio Nazionale delle Ricerche, Padua (Italy) (Z. Naturforsch. 27 b, 813—817 [1972]; received March 20/April 24, 1972) The Authors have studied the biosynthesis of some furocoumarins contained in Ruta graveolens. Labeled 5,7- and 7,8-dihydroxycoumarins have been administered to the herb, however practically no incorporation of radioactivity was observed in the isolated furocoumarins. Moreover, with the aim to study in a more detailed way the role of rutaretin and marmesin, trapping experiments have been performed administering to the herb labeled umbelliferone together with unlabeled rutaretin and marmesin respectively. A very effective incorporation was observed into marmesin, in lesser extent into rutaretin. In trapping experiments carried out using labeled rutaretin together with unlabeled marmesin and "vice versa", the results obtained clearly show that while marmesin was converted into ruta- retin in a very effective way, rutaretin was transformed into marmesin only in a smaller extent. The Authors suggest the biogenetic origin of rutaretin and moreover formulate a new and more detailed aspect of the scheme for the biosynthetic pathway of furocoumarins in Ruta graveolens. The biogenesis of furocoumarins has been studied (III); from this compound other naturally occur- in various plants [Ficus carica 2, Pimpinella ring furocoumarins, for instance bergapten (IV) magna3'4, Ammi majus, Angelica archangelica, and xanthotoxin (V) can derive by means of hy- Heracleum lanatum, Ruta graveolens 5-9, Pastinaca droxylation and O-alkylation reactions. sativa10]. The general scheme of the biosynthetic More recently we have found that not only hy- pathway appears to be well established: it involves droxylation and O-alkylation reactions, but also de- in a first stage the formation of a 7-hydroxycouma- methoxylation reactions can take place in plants: in rin-derivative (the biogenesis of coumarins has fact we have observed that a reciprocal conversion already been largely studied); successively the furan between psoralen and xanthotoxin can occur6; ring is formed on this compound through an iso- moreover, 4',5' - dihydropsoralen, 4',5' - dihydro- prenylation reaction leading to a 4',5'-dihydrofuro- bergapten and 4/,5'-dihydroxanthotoxin proved to coumarin-intermediate; finally this last is trans- be precursors not only of the corresponding furo- formed into furocoumarin-derivative. coumarins (psoralen, bergapten and xanthotoxin, It has been found that 7-hydroxycoumarin (I) respectively) but also of the other two, although (umbelliferone) is the most effective general pre- only to a small extent5. cursor at the first stage. Recently BROWN 7- 8 sug- Concerning Ruta graveolens, some doubt could gested that the only natural intermediate at the stage arise about the preceding biogenetic scheme, be- of 4',5'-dihydrofurocoumarin-derivative is marme- cause marmesin till now has not been found present sin (II), which is then transformed into psoralen in this plant, although feeding experiments have OCH3 / ykAA, IV ovo v CH3 ^ II IH O'^V^O'^'O Fig. 1. General biosynthetic 0CH3 pathway proposed for psoralen V (III), bergapten(IV) and xantho- toxin (V). Requests for reprints should be sent to Dr. F. DALL'ACQUA, Universitä di Padova, Istituto di Chimica Farmaceutica, Via Marzolo 5, 35100 Padova (Italy). Dieses Werk wurde im Jahr 2013 vom Verlag Zeitschrift für Naturforschung This work has been digitalized and published in 2013 by Verlag Zeitschrift in Zusammenarbeit mit der Max-Planck-Gesellschaft zur Förderung der für Naturforschung in cooperation with the Max Planck Society for the Wissenschaften e.V. digitalisiert und unter folgender Lizenz veröffentlicht: Advancement of Science under a Creative Commons Attribution Creative Commons Namensnennung 4.0 Lizenz. 4.0 International License. 814 F. DALL'ACQUA, A. CAPOZZI, S. MARCIANI, AND G. CAPORALE demonstrated that it may be a valid precursor for experiment was comprehended between the range furocoumarins (psoralen, bergapten and xantho- 10 —12 g. This was placed into 100 ml beakers con- taining a mixture formed by adding to the aqueous toxin) and especially for psoralen. On the other solution of the labeled compound to be administered, hand, another 4 ,5 -dihydrofurocoumarin-derivative an equal volume of an "aqueous nutritious solution" 17. has been isolated from Ruta graveolens, that is ruta- The system was illuminated with 500 W Osram HWL retin (VI), which is an 8-hydroxyderivative of mar- lamps; "metabolism time" lasted 7 days for feeding experiments with umbelliferone and its hydroxy- mesin n. derivatives, while for trapping experiments it lasted 54 hours. During the metabolic period "aqueous nutri- tious solution" was added to maintain constant the level of the liquid layer in the beakers. 3 OH VI Trapping experiments Fig. 2. Molecular structure of rutaretin (VI). Two different types of trapping experiments have been performed A) and B) : Very recently we have found that rutaretin (VI) A) 2.4 mg of tritiated umbelliferone was solubilized is well incorporated specifically into xanthotoxin in 40 ml of distilled water and successively 16 mg of unlabeled rutaretin was also dissolved in the same and also into psoralen and bergapten, even to a solution and this was administered to the herb as indi- 6 lesser extent . It may therefore be the natural cated in the section "feeding procedure". Analogous 4',5'-dihydrofurocoumarin-intermediate, at least for experiment was performed using unlabeled marmesin the biosynthesis of xanthotoxin. (15 mg) together with tritiated umbelliferone (2.6 mg); The studies reported in this paper have been per- B) 3 mg of tritiated rutaretin together with 10 mg of unlabeled marmesin were solubilized in 40 ml of formed to obtain further experimental information distilled water and this solution was then administered on the role of rutaretin, on its biogenetic origin and to Ruta graveolens as reported in the "feeding proce- on the possibility that marmesin also may be a phy- dure". Parallel experiment was carried out using 3 mg siological intermediate, perhaps present only in a of tritiated marmesin and 10 mg of unlabeled rutaretin, operating in the same experimental conditions. very small amount. The results obtained feeding Ruta graveolens with Isolation and purification of furocoumarins and of 5,7-dihydroxycoumarin (VII) and with 7,8-dihy- rutaretin and marmesin droxycoumarin (VIII) (daphnetin), as well as per- Isolation and purification of psoralen (III), bergap- forming some trapping experiments, in which marme- ten (IV) and xanthotoxin (V) were performed fol- lowing a procedure described elsewhere 6. sin and rutaretin were involved, allowed us to for- Rutaretin (VI) and marmesin (II) were isolated mulate a more detailed scheme for the biosynthetic and purified in a way similar to that described for pathway of psoralen and xanthotoxin in Ruta gra- furocoumarins with little change in the procedure for veolens. preparing the "coumarinic extract"1,2'18 as follows: the etheral coumarinic extract was washed three times with an equal volume of saturated sodium bicarbonate Materials and Methods aqueous solution. After this treatment, while marmesin and furocoumarins remained in the etheral solution 7-hydroxycoumarin or umbelliferone (I) 12, 5,7-di- (A), rutaretin passed into the aqueous bicarbonate hydroxycoumarin (VII) 13 and 7,8-dihydroxycoumarin phase; this last phase was acidified with 2n HCl and (VIII) 14 have been prepared in this Institute. then extracted with ether (B). From the two etheral Rutaretin (VI) 11 (extracted from Ruta graveo- 15 extracts (A) and (B) the solvent was distilled and the lens) and marmesin (II) (extracted from Aegle mar- residues were chromatographed as follows: melos, Correa) have kindly been provided by Prof. Dr. a) thin layer silica gel preparative chromatography G. SCHNEIDER and Prof. Dr. A. CHATTERJEE respecti- vely. 3H labeling procedure of all these substances has (Merck cat. 5717) using as solvent of development ethyl acetate : cyclohexane (3 : 1, v/v) ; been carried out according to the WILZBACH method 16. Chemical and radiochemical purification of labeled b) thin layer silica gel analytical chromatography compounds has been performed following a procedure (Merck cat. 5715) : solvent of development ethyl ace- described elsewhere 2. The specific radioactivity of these tate : cyclohexane (2 : 1, v/v) : at this stage chemical compounds is reported in Tables I, II and III. and radiochemical purity of the substances were tested. Spectrophotometrical measurements and radiochemical Feeding procedure determinations Cut ends of Ruta graveolens herb were employed; The different ethanolic solutions containing the generally the dry weight of this material for every various isolated compounds were examined spectro- BIOSYNTHESIS OF FUROCOUMARINS 815 photometrically both recording their u.v. spectra using It is well known that the biogenetic route starting a 124 double beam model Perkin-Elmer instrument and from umbelliferone and leading to furocoumarins successively determining their absorbance at X max involves 4',5'-dihydrointermediates; in the case of by means of a CF 4 Optica single beam spectro- photometer. Radiochemical measurements were per- Ruta
Load more

Recommended publications
  • Appendix Human and Rat Liver Cytochromes P450: Functional
    Appendix Human and Rat Liver Cytochromes P450: Functional Markers, Diagnostic Inhibitor Probes, and Parameters Frequently Used in P450 Studies Maria Almira Correia The tables in this appendix summarize the rel­ different P450 isoforms included in its evaluation ative functional selectivities of substrates and as well as the range of substrate/inhibitor concen­ inhibitors for the major human and rat liver trations tested. Second, substrates and inhibitors C3^ochrome P450 isoforms (P450s). These hepatic determined to be "relatively selective" for a human isoforms are well recognized to catalytically par­ liver isoform, may not necessarily be so for its rat ticipate in the metabolism of chemically diverse liver ortholog, and vice versa. Third, the relative endo- and xenobiotics including drugs, and in the metabolic contribution of a P450 isoform to the case of human liver P450s to thus contribute to in vivo hepatic metabolism of a given drug is directly clinically adverse drug-drug interactions. Conse­ proportional to the relative hepatic microsomal quently, these P450s are the targets of intense abundance of that isoform and its affinity for that scrutiny in the pharmaceutical screening of exist­ compound, irrespective of its in vitro high meta­ ing or novel chemical agents of potential clinical bolic profile assessed under "optimized" condi­ relevance for drug development. At a more basic tions. This issue arises because recent advances in level, these tables provide information on estab­ recombinant P450 technology have made unprece­ lished and/or potential diagnostic tools for the dented amounts of purified human liver enzymes identification and/or characterization of the meta­ readily available for comparative in vitro charac­ bolic role of each individual P450 in the disposition terization of drug metabolism, at relative P450 of an as yet uncharacterized xeno- or endobiotic.
    [Show full text]
  • Identification and Functional Characterization of the First Two
    Identification and functional characterization of the first two aromatic prenyltransferases implicated in the biosynthesis of furanocoumarins and prenylated coumarins in two plant families: Rutaceae and Apiaceae Fazeelat Karamat To cite this version: Fazeelat Karamat. Identification and functional characterization of the first two aromatic prenyl- transferases implicated in the biosynthesis of furanocoumarins and prenylated coumarins in two plant families: Rutaceae and Apiaceae. Agronomy. Université de Lorraine, 2013. English. NNT : 2013LORR0029. tel-01749560 HAL Id: tel-01749560 https://hal.univ-lorraine.fr/tel-01749560 Submitted on 29 Mar 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. AVERTISSEMENT Ce document est le fruit d'un long travail approuvé par le jury de soutenance et mis à disposition de l'ensemble de la communauté universitaire élargie. Il est soumis à la propriété intellectuelle de l'auteur. Ceci implique une obligation de citation et de référencement lors de l’utilisation de ce document. D'autre part, toute contrefaçon, plagiat,
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,563,754 B2 Orlow Et Al
    US008563754B2 (12) United States Patent (10) Patent No.: US 8,563,754 B2 Orlow et al. (45) Date of Patent: Oct. 22, 2013 (54) COMPOUNDS, COMPOSITIONS AND FOREIGN PATENT DOCUMENTS METHODS FOR PREVENTING SKIN JP 2004-352658 * 12/2004 DARKENING WO 99.09011 2, 1999 WO 9964O25 12/1999 (75) Inventors: Seth J. Orlow, New York, NY (US); Li WO OO62742 10, 2000 Ni Komatsu, Clarksville, MD (US) WO 01.01131 1, 2001 WO O2098347 12/2002 WO 2007110415 10/2007 (73) Assignee: New York University, New York, NY WO WO2O11,068595 * 6, 2011 (US) OTHER PUBLICATIONS (*) Notice: Subject to any disclaimer, the term of this Silverman et al., “The Organic Chemistry of Drug Design and Drug patent is extended or adjusted under 35 Action” Published 1992 by Academic Press, pp. 352-397.* U.S.C. 154(b) by 320 days. Vippagunta et al., “Crystalline Solids' Advanved Drug Delivery Reviews (2001) vol. 48 pp. 3-26.* Jain et al., “Polymorphism in Pharmacy” Indian Drugs (1986) vol. 23 (21) Appl. No.: 13/015,882 No. 6 pp. 315-329.* Braga et al., “Making Crystals from Crystals: a green route to crystal (22) Filed: Jan. 28, 2011 engineering and polymorphism” Chemcomm (2005) pp. 3635 3645.* (65) Prior Publication Data Lieberman et al., “Pharmaceutical Dosage Forms: Tablets' published 1990 by Marcel Dekker, Inc., pp. 462-472.* US 2011 FO190229 A1 Aug. 4, 2011 English machine translation of JP2004-352658, published Dec. 6. 2004. Suzuki et al., “Cancer Preventive Agents. Part5. Anti-tumor-Promot ing Effects of Coumarins and Related Compounds on Epstein-Barr Related U.S.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0269772 A1 Califano Et Al
    US 20090269772A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0269772 A1 Califano et al. (43) Pub. Date: Oct. 29, 2009 (54) SYSTEMS AND METHODS FOR Publication Classification IDENTIFYING COMBINATIONS OF (51) Int. Cl. COMPOUNDS OF THERAPEUTIC INTEREST CI2O I/68 (2006.01) CI2O 1/02 (2006.01) (76) Inventors: Andrea Califano, New York, NY G06N 5/02 (2006.01) (US); Riccardo Dalla-Favera, New (52) U.S. Cl. ........... 435/6: 435/29: 706/54; 707/E17.014 York, NY (US); Owen A. (57) ABSTRACT O'Connor, New York, NY (US) Systems, methods, and apparatus for searching for a combi nation of compounds of therapeutic interest are provided. Correspondence Address: Cell-based assays are performed, each cell-based assay JONES DAY exposing a different sample of cells to a different compound 222 EAST 41ST ST in a plurality of compounds. From the cell-based assays, a NEW YORK, NY 10017 (US) Subset of the tested compounds is selected. For each respec tive compound in the Subset, a molecular abundance profile from cells exposed to the respective compound is measured. (21) Appl. No.: 12/432,579 Targets of transcription factors and post-translational modu lators of transcription factor activity are inferred from the (22) Filed: Apr. 29, 2009 molecular abundance profile data using information theoretic measures. This data is used to construct an interaction net Related U.S. Application Data work. Variances in edges in the interaction network are used to determine the drug activity profile of compounds in the (60) Provisional application No. 61/048.875, filed on Apr.
    [Show full text]
  • Tolerance and Metabolism of Furanocoumarins by the Phytopathogenic Fungus Gibberella Pulicaris (Fusarium Sambucinum)
    Phytochemistry, Vol. 28, No. II, pp. 2963-2969,1989. 0031-9422/89 S3.00 +0.00 Printed in Great Britain. © 1989 Pergamon Press pic TOLERANCE AND METABOLISM OF FURANOCOUMARINS BY THE PHYTOPATHOGENIC FUNGUS GIBBERELLA PULICARIS (FUSARIUM SAMBUCINUM) ANNE E. DESJARDINS,* GAYLAND F. SPENCER and RONALD D. PLATTNER U.S. Department of Agriculture, Agricultural Research Service, Northern Regional Research Center, 1815 North University Street, Peoria, IL 61604, U.S.A. (Received in revised form 3 April 1989) Key Word Index-Pastinaca sativa; Umbellifereae; parsnip; Gibberella pulicaris (Fusarium sambucinum); phyto­ alexin metabolism; furanocoumarins. Abstract-Sixty-two strains of Gibberella pulicaris (anamorph: Fusarium sambucinum) from diseased plants and from soil were tested for tolerance of the furanocoumarin xanthotoxin in vitro. Twenty-one (88%) of the plant-derived strains and two (5%) ofthe soil-derived strains were highly tolerant ofxanthotoxin. Sixteen selected strains were tested further against 16 furanocoumarins or furanocoumarin precursors. All plant-derived strains tested were highly tolerant of and, in most cases, able to completely metabolize all 16 compounds. Most soil-derived strains tested were tolerant of furanocoumarin precursors but sensitive to certain furanocoumarins. Linear compounds methoxylated at C-8 appeared more toxic than both those unsubstituted and those with longer-chain ethers. Tolerance of angelicin, xanthotoxin, pimpinellin and isopimpinellin correlated in large part with their metabolism. All strains that were
    [Show full text]
  • Biosynthesis of Psoralens
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Volume 239, number 2, 263-265 FEB 06461 November 1988 Biosynthesis of psoralens Psoralen Smonooxygenase activity from elicitor-treated Ammi majus cells Daria Hamerski and Ulrich Matern Lehrstuhlfiir Biochemie der PJanzen. Biologisches Institut II, Universitiit Freiburg, Schiinzlestr. I, D-7800 Freiburg, FRG Received 31 August 1988 Microsomes prepared from cultured Ammi mujus cells that had been challenged for 14 h with an elicitor derived from the cell walls of Phytophthora megasperma f.sp. glycineu (Pmg) converted psoralen to bergaptol(5-hydroxypsoralen) in the presence of NADPH and oxygen. The enzymatic activity was characterized as an inducible cytochrome-P-450-depen- dent monooxygenase associated with the endoplasmic reticulum. All of the steps involved in bergapten (5methoxypsora- len) biosynthesis in Ammi majus have now been demonstrated in vitro. The results suggest that bergaptol and not hydrox- ymarmesin in the precursor of bergapten. Elicitor enzyme induction; Psoralen biosynthesis; Cytochrome P-450 monooxygenase; Furanocoumarin phytoalexin; (Ammi mujus) 1. INTRODUCTION Since we have never observed the formation of 5hydroxymarmesin in incubations employing Suspension cultures of Ammi majus produce ( + )-marmesin as a substrate, we have investigated large quantities of linear furanocoumarins upon whether extracts from these cells can efficiently elicitor treatment and appear, therefore, well convert psoralen to bergaptol (fig. 1). suited for enzymatic investigations into their biosynthesis [I ,2]. The pathway leading to bergapten (5-methoxypsoralen) biosynthesis sug- 2. MATERIALS AND METHODS gested on the basis of precursor studies has re- mained under debate, since, formally, it may 2.1.
    [Show full text]
  • Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest
    molecules Review Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest Renato Bruni 1 , Davide Barreca 2 , Michele Protti 3 , Virginia Brighenti 4, Laura Righetti 1 , Lisa Anceschi 4, Laura Mercolini 3 , Stefania Benvenuti 4, Giuseppe Gattuso 2 and Federica Pellati 4,* 1 Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy; [email protected] (R.B.); [email protected] (L.R.) 2 Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno d’Alcontres 31, 98166 Messina, Italy; [email protected] (D.B.); [email protected] (G.G.) 3 Department of Pharmacy and Biotechnology (FaBiT), Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy; [email protected] (M.P.); [email protected] (L.M.) 4 Department of Life Sciences, University of Modena and Reggio Emilia, Via G. Campi 103, 41125 Modena, Italy; [email protected] (V.B.); [email protected] (L.A.); [email protected] (S.B.) * Correspondence: [email protected]; Tel.: +39-059-205-8565 Received: 11 May 2019; Accepted: 6 June 2019; Published: 8 June 2019 Abstract: The aim of this work is to provide a critical review of plant furanocoumarins from different points of view, including their chemistry and biosynthetic pathways to their extraction, analysis, and synthesis, to the main biological activities found for these active compounds, in order to highlight their potential within pharmaceutical science. The limits and the possible improvements needed for research involving these molecules are also highlighted and discussed.
    [Show full text]
  • Reference Substances 2018/2019
    Reference Substances 2018 / 2019 Reference Substances Reference 2018/2019 Contents | 3 Contents Page Welcome 4 Our Services 5 Reference Substances 6 Index I: Alphabetical List of Reference Substances and Synonyms 156 Index II: Plant-specific Marker Compounds 176 Index III: CAS Registry Numbers 214 Index IV: Substance Classification 224 Our Reference Substance Team 234 Order Information 237 Order Form 238 Prices insert 4 | Welcome Welcome to our new 2018 / 2019 catalogue! PhytoLab proudly presents the new you will also be able to view exemplary Index I contains an alphabetical list of all 2018 / 2019 catalogue of phyproof® certificates of analysis and download substances and their synonyms. It pro- Reference Substances. The seventh edition material safety data sheets (MSDS). vides information which name of a refer- of our catalogue now contains well over ence substance is used in this catalogue 1300 phytochemicals. As part of our We very much hope that our product and guides you directly to the correct mission to be your leading supplier of portfolio meets your expectations. The list page. herbal reference substances PhytoLab of substances will be expanded even has characterized them as primary further in the future, based upon current If you are a planning to analyse a specific reference substances and will supply regulatory requirements and new scientific plant please look for the botanical them together with the comprehensive developments. The most recent information name in Index II. It will inform you about certificates of analysis you are familiar will always be available on our web site. common marker compounds for this herb. with.
    [Show full text]
  • Mitigation of NADPH Oxidase 2 Activity As a Strategy to Inhibit Peroxynitrite Formation
    Mitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation Jacek Zielonka, Monika Zielonka, Lynn Verplank, Gang Cheng, Micael Hardy, Olivier Ouari, Mehmet Menaf Ayhan, Radoslaw Podsiadly, Adam Sikora, J Lambeth, et al. To cite this version: Jacek Zielonka, Monika Zielonka, Lynn Verplank, Gang Cheng, Micael Hardy, et al.. Mitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation. Journal of Biologi- cal Chemistry, American Society for Biochemistry and Molecular Biology, 2016, 291, pp.7029-7044. 10.1074/jbc.M115.702787. hal-01400640 HAL Id: hal-01400640 https://hal-amu.archives-ouvertes.fr/hal-01400640 Submitted on 28 Nov 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. JBC Papers in Press. Published on February 2, 2016 as Manuscript M115.702787 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M115.702787 Nox2 inhibition as anti-nitration strategy Mitigation of NADPH oxidase 2 activity as a strategy to inhibit peroxynitrite formation Jacek Zielonka1, Monika Zielonka1, Lynn
    [Show full text]
  • Biosynthesis of Furocoumarins: Further Studies on Ruta Graveolens
    BIOSYNTHESIS OF FUROCOUMARINS 813 Biosynthesis of Furocoumarins: Further Studies on Ruta graveolens F. DALL'ACQUA, A. CAPOZZI, S. MARCIANI, and G. CAPORALE Institute of Pharmaceutical Chemistry of the University, Centro di Studio per la Chimica del Farmaco e dei Prodotti biologicamente attivi del Consiglio Nazionale delle Ricerche, Padua (Italy) (Z. Naturforsch. 27 b, 813—817 [1972]; received March 20/April 24, 1972) The Authors have studied the biosynthesis of some furocoumarins contained in Ruta graveolens. Labeled 5,7- and 7,8-dihydroxycoumarins have been administered to the herb, however practically no incorporation of radioactivity was observed in the isolated furocoumarins. Moreover, with the aim to study in a more detailed way the role of rutaretin and marmesin, trapping experiments have been performed administering to the herb labeled umbelliferone together with unlabeled rutaretin and marmesin respectively. A very effective incorporation was observed into marmesin, in lesser extent into rutaretin. In trapping experiments carried out using labeled rutaretin together with unlabeled marmesin and "vice versa", the results obtained clearly show that while marmesin was converted into ruta- retin in a very effective way, rutaretin was transformed into marmesin only in a smaller extent. The Authors suggest the biogenetic origin of rutaretin and moreover formulate a new and more detailed aspect of the scheme for the biosynthetic pathway of furocoumarins in Ruta graveolens. The biogenesis of furocoumarins has been studied (III); from this compound other naturally occur- in various plants [Ficus carica 2, Pimpinella ring furocoumarins, for instance bergapten (IV) magna3'4, Ammi majus, Angelica archangelica, and xanthotoxin (V) can derive by means of hy- Heracleum lanatum, Ruta graveolens 5-9, Pastinaca droxylation and O-alkylation reactions.
    [Show full text]
  • Reference Substances
    Reference Substances 2020/2021 Contents | 3 Contents Page Welcome 4 Our Services 5 Reference Substances 6 Index I: Alphabetical List of Reference Substances and Synonyms 168 Index II: CAS Registry Numbers 190 Index III: Substance Classification 200 Our Reference Substance Team 212 Distributors & Area Representatives 213 Ordering Information 216 Order Form 226 4 | Welcome Welcome to our new 2020 / 2021 catalogue! PhytoLab proudly presents the new for all reference substances are available Index I contains an alphabetical list of 2020/2021 catalogue of phyproof® for download. all substances and their synonyms. It Reference Substances. The eighth edition provides information which name of a of our catalogue now contains well over We very much hope that our product reference substance is used in this 1400 natural products. As part of our portfolio meets your expectations. The catalogue and guides you directly to mission to be your leading supplier of list of substances will be expanded even the correct page. herbal reference substances PhytoLab further in the future, based upon current has characterized them as primary regulatory requirements and new Index II contains a list of the CAS registry reference substances and will supply scientific developments. The most recent numbers for each reference substance. them together with the comprehensive information will always be available on certificates of analysis you are familiar our web site. However, if our product list Finally, in Index III we have sorted all with. does not include the substance you are reference substances by structure based looking for please do not hesitate to get on the class of natural compounds that Our phyproof® Reference Substances will in touch with us.
    [Show full text]
  • Reflection Paper on Risk Associated with the Use of Herbals Containing
    European Medicines Agency Post-authorisation Evaluation of Medicines for Human Use London, 31 October 2007 Doc. Ref. EMEA/HMPC/317913/2006 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL REFLECTION PAPER ON THE RISKS ASSOCIATED WITH FUROCOUMARINS CONTAINED IN PREPARATIONS OF ANGELICA ARCHANGELICA L. DRAFT AGREED BY THE HMPC October 2006 ADOPTION BY HMPC FOR RELEASE FOR CONSULTATION 11 January 2007 END OF CONSULTATION (DEADLINE FOR COMMENTS) 15 May 2007 ADOPTION BY HMPC 31 October 2007 KEYWORDS HMPC, herbal medicinal products, Angelica archangelica L., furocoumarins, phototoxicity 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 75 23 70 51 E-mail: [email protected] http://www.emea.europa.eu ©EMEA 2007 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged DRAFT REFLECTION PAPER ON THE RISKS ASSOCIATED WITH FUROCOUMARINS CONTAINED IN PREPARATION OF ANGELICA ARCHANGELICA L. TABLE OF CONTENTS 1. INTRODUCTION (BACKGROUND) ........................................................................................ 3 2. SAFETY EVALUATION OF FUROCOUMARINS (CAS NUMBER 66-97-7) ..................... 3 2.1 PHOTOTOXICITY OF FUROCOUMARINS .................................................................................... 3 2.2 CARCINOGENIC POTENTIAL OF FUROCOUMARINS ................................................................... 4 2.3 MECHANISM OF ACTION .........................................................................................................
    [Show full text]